Human Metabolome Technologies, Inc. (6090.T)

JPY 699.0

(2.79%)

Net Debt Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual net debt in 2023 was -1.56 Billion JPY , down -9.22% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly net debt in 2023 FY was -1.56 Billion JPY , down -9.22% from previous quarter.
  • Human Metabolome Technologies, Inc. reported annual net debt of -1.43 Billion JPY in 2022, down -12.48% from previous year.
  • Human Metabolome Technologies, Inc. reported annual net debt of -1.27 Billion JPY in 2021, down -16.41% from previous year.
  • Human Metabolome Technologies, Inc. reported quarterly net debt of -1.56 Billion JPY for 2023 Q4, down -9.67% from previous quarter.
  • Human Metabolome Technologies, Inc. reported quarterly net debt of -1.42 Billion JPY for 2023 Q3, down -18.2% from previous quarter.

Annual Net Debt Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Net Debt of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -1.56 Billion JPY -9.22%
2022 -1.43 Billion JPY -12.48%
2021 -1.27 Billion JPY -16.41%
2020 -1.09 Billion JPY 0.63%
2019 -1.09 Billion JPY 0.0%

Peer Net Debt Comparison of Human Metabolome Technologies, Inc.

Name Net Debt Net Debt Difference
Shin Nippon Biomedical Laboratories, Ltd. 16.05 Billion JPY 109.73%
DNA Chip Research Inc. -388.4 Million JPY -302.209%
Cosmo Bio Company,Limited -2.8 Billion JPY 44.326%
H.U. Group Holdings, Inc. 41.99 Billion JPY 103.72%
FALCO HOLDINGS Co., Ltd. -9.24 Billion JPY 83.108%
BML, Inc. -68.84 Billion JPY 97.731%
Precision System Science Co., Ltd. -548.58 Million JPY -184.769%